Cargando…

Correction: Mettl14 inhibits bladder TIC self-renewal and bladder tumorigenesis through N6 - methyladenosine of Notch1

Detalles Bibliográficos
Autores principales:	Gu, Chaohui, Wang, Zhiyu, Zhou, Naichun, Li, Guanru, Kou, Yiping, Luo, Yang, Wang, Yidi, Yang, Jinjian, Tian, Fengyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835208/ https://www.ncbi.nlm.nih.gov/pubmed/36635770 http://dx.doi.org/10.1186/s12943-023-01717-x

Ejemplares similares

Mettl14 inhibits bladder TIC self-renewal and bladder tumorigenesis through N(6)-methyladenosine of Notch1
por: Gu, Chaohui, et al.
Publicado: (2019)

circGprc5a Promoted Bladder Oncogenesis and Metastasis through Gprc5a-Targeting Peptide
por: Gu, Chaohui, et al.
Publicado: (2018)

MicroRNA-212 inhibits the proliferation, migration and invasion of renal cell carcinoma by targeting X-linked inhibitor of apoptosis protein (XIAP)
por: Gu, Chaohui, et al.
Publicado: (2017)

UBAC2 promotes bladder cancer proliferation through BCRC-3/miRNA-182-5p/p27 axis
por: Gu, Chaohui, et al.
Publicado: (2020)

Solution structure of the RNA recognition domain of METTL3-METTL14 N(6)-methyladenosine methyltransferase
por: Huang, Jinbo, et al.
Publicado: (2018)

LncHOXA10 drives liver TICs self-renewal and tumorigenesis via HOXA10 transcription activation
por: Shao, Ming, et al.
Publicado: (2018)

Deficiency of Mettl3 in Bladder Cancer Stem Cells Inhibits Bladder Cancer Progression and Angiogenesis
por: Wang, Ganping, et al.
Publicado: (2021)

p53 destabilizing protein skews asymmetric division and enhances NOTCH activation to direct self-renewal of TICs
por: Choi, Hye Yeon, et al.
Publicado: (2020)

N6-methyladenosine methyltransferase METTL3 affects the phenotype of cerebral arteriovenous malformation via modulating Notch signaling pathway
por: Wang, Lin-jian, et al.
Publicado: (2020)

Corrigendum: Deficiency of Mettl3 in Bladder Cancer Stem Cells Inhibits Bladder Cancer Progression and Angiogenesis
por: Wang, Ganping, et al.
Publicado: (2021)

N(6)-methyladenosine METTL3 promotes cervical cancer tumorigenesis and Warburg effect through YTHDF1/HK2 modification
por: Wang, Qianqing, et al.
Publicado: (2020)

Mutations of METTL3 predict response to neoadjuvant chemotherapy in muscle-invasive bladder cancer
por: Yang, Zhao, et al.
Publicado: (2021)

Bladder cancer and the Notch pathway
por: Fernandez-Marcos, Pablo J., et al.
Publicado: (2015)

N (6)-methyladenosine modification and METTL3 modulate enterovirus 71 replication
por: Hao, Haojie, et al.
Publicado: (2019)

The N6-methyladenosine METTL3 regulates tumorigenesis and glycolysis by mediating m6A methylation of the tumor suppressor LATS1 in breast cancer
por: Xu, Youqin, et al.
Publicado: (2023)

Thrombomodulin expression regulates tumorigenesis in bladder cancer
por: Wu, Chun-Te, et al.
Publicado: (2014)

METTL3/YTHDF2 m(6)A axis promotes tumorigenesis by degrading SETD7 and KLF4 mRNAs in bladder cancer
por: Xie, Haiyun, et al.
Publicado: (2020)

Combination of C-Reactive Protein and Neutrophil-to-Lymphocyte Ratio as a Novel Prognostic Index in Patients With Bladder Cancer After Radical Cystectomy
por: Wang, Yidi, et al.
Publicado: (2021)

A novel hedgehog inhibitor iG2 suppresses tumorigenesis by impairing self‐renewal in human bladder cancer
por: Zhu, Lihong, et al.
Publicado: (2016)

METTL13 is downregulated in bladder carcinoma and suppresses cell proliferation, migration and invasion
por: Zhang, Zhe, et al.
Publicado: (2016)

METTL3-mediated N(6)-methyladenosine mRNA modification enhances long-term memory consolidation
por: Zhang, Zeyu, et al.
Publicado: (2018)

METTL3-mediated mRNA N(6)-methyladenosine is required for oocyte and follicle development in mice
por: Mu, Haiyuan, et al.
Publicado: (2021)

The C228T mutation of TERT promoter frequently occurs in bladder cancer stem cells and contributes to tumorigenesis of bladder cancer
por: Li, Chong, et al.
Publicado: (2015)

N(6)-Methyladenosine METTL3 Modulates the Proliferation and Apoptosis of Lens Epithelial Cells in Diabetic Cataract
por: Yang, Jun, et al.
Publicado: (2020)

N(6)-methyladenosine modification of ITGA6 mRNA promotes the development and progression of bladder cancer
por: Jin, Huan, et al.
Publicado: (2019)

LMTK3 promotes tumorigenesis in bladder cancer via the ERK/MAPK pathway
por: Jiang, Tao, et al.
Publicado: (2020)

N6-methyladenosine-related lncRNAs in combination with computational histopathology and radiomics predict the prognosis of bladder cancer
por: Huang, Ziye, et al.
Publicado: (2022)

Current Advances in N6-Methyladenosine Methylation Modification During Bladder Cancer
por: Liu, Qiang
Publicado: (2022)

Exploration of N6-Methyladenosine Profiles of mRNAs and the Function of METTL3 in Atherosclerosis
por: Zhou, Yaqing, et al.
Publicado: (2022)

Comprehensive Analysis of N6-methyladenosine Modification Patterns Associated With Multiomic Characteristics of Bladder Cancer
por: Liu, Jingchao, et al.
Publicado: (2021)

METTL1‐m(7)G‐EGFR/EFEMP1 axis promotes the bladder cancer development
por: Ying, Xiaoling, et al.
Publicado: (2021)

METTL14 is a chromatin regulator independent of its RNA N(6)-methyladenosine methyltransferase activity
por: Dou, Xiaoyang, et al.
Publicado: (2023)

Depletion of CDC5L inhibits bladder cancer tumorigenesis
por: Zhang, Ziwei, et al.
Publicado: (2020)

Aberrantly expressed microRNAs in the context of bladder tumorigenesis
por: Lee, Jong-Young, et al.
Publicado: (2016)

Expression of Spred2 in the urothelial tumorigenesis of the urinary bladder
por: Oda, Shinsuke, et al.
Publicado: (2021)

N6-Methyladenosine Methyltransferase METTL14-Mediated Autophagy in Malignant Development of Oral Squamous Cell Carcinoma
por: Wang, Fang, et al.
Publicado: (2021)

METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer
por: Yue, Ben, et al.
Publicado: (2019)

METTL3-Mediated N6-Methyladenosine Modification Is Involved in the Dysregulation of NRIP1 Expression in Down Syndrome
por: Shi, Weili, et al.
Publicado: (2021)

Reinvestigating the clinical relevance of the m(6)A writer METTL3 in urothelial carcinoma of the bladder
por: Koch, Jonas, et al.
Publicado: (2023)

Retraction Note: METTL13 is downregulated in bladder carcinoma and suppresses cell proliferation, migration and invasion
por: Zhang, Zhe, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vgeuhb96akblip25rgbjuj9fmf